The tumor mutational landscape of BRCA2-deficient primary and metastatic prostate cancer
Open Access
- 17 June 2022
- journal article
- research article
- Published by Springer Nature in npj Precision Oncology
- Vol. 6 (1) , 1-9
Abstract
Carriers of germlineBRCA2pathogenic sequence variants have elevated aggressive prostate cancer risk and are candidates for precision oncology treatments. We examined whetherBRCA2-deficient (BRCA2d) prostate tumors have distinct genomic alterations compared withBRCA2-intact (BRCA2i) tumors. Among 2536 primary and 899 metastatic prostate tumors from the ICGC, GENIE, and TCGA databases, we identified 138 primary and 85 metastaticBRCA2dtumors. Total tumor mutation burden (TMB) was higher among primaryBRCA2dtumors, although pathogenic TMB did not differ by tumorBRCA2status. Pathogenic and total single nucleotide variant (SNV) frequencies atKMT2Dwere higher inBRCA2dprimary tumors, as was the total SNV frequency atKMT2DinBRCA2dmetastatic tumors. Homozygous deletions atNEK3,RB1, andAPCwere enriched inBRCA2dprimary tumors, andRB1deletions in metastaticBRCA2dtumors as well.TMPRSS2-ETV1fusions were more common inBRCA2dtumors. These results identify somatic alterations that hallmark etiological and prognostic differences betweenBRCA2dandBRCA2iprostate tumors.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01-CA207365, R00-CA245900)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
This publication has 49 references indexed in Scilit:
- Poly (ADP-ribose) polymerase (PARP) inhibitors for the treatment of advanced germline BRCA2 mutant prostate cancerAnnals of Oncology, 2013
- A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEffFly, 2012
- BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patientsBritish Journal of Cancer, 2011
- Decreased Prostate Cancer-Specific Survival of Men withBRCA2 Mutations from Multiple Breast Cancer FamiliesCancer Prevention Research, 2011
- GeneCards Version 3: the human gene integratorDatabase: The Journal of Biological Databases and Curation, 2010
- Predisposition for TMPRSS2-ERG Fusion in Prostate Cancer by Variants in DNA Repair GenesCancer Epidemiology, Biomarkers & Prevention, 2009
- Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotypeBritish Journal of Cancer, 2008
- High Promoter Methylation Levels of APC Predict Poor Prognosis in Sextant Biopsies from Prostate Cancer PatientsClinical Cancer Research, 2007
- Is There Any Association BetweenNek3and Cancers with Frequent 13q14 Deletion?Cancer Investigation, 2006
- Cancer Risks in BRCA2 Mutation CarriersJNCI: Journal of the National Cancer Institute, 1999